NM_001164507.2:c.21348T>A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001164507.2(NEB):c.21348T>A(p.Asp7116Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D7116N) has been classified as Likely benign.
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001164507.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NEB | NM_001164507.2 | MANE Plus Clinical | c.21348T>A | p.Asp7116Glu | missense | Exon 143 of 182 | NP_001157979.2 | ||
| NEB | NM_001164508.2 | MANE Select | c.21313-738T>A | intron | N/A | NP_001157980.2 | |||
| NEB | NM_001271208.2 | c.21348T>A | p.Asp7116Glu | missense | Exon 143 of 183 | NP_001258137.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000427231.7 | TSL:5 MANE Plus Clinical | c.21348T>A | p.Asp7116Glu | missense | Exon 143 of 182 | ENSP00000416578.2 | ||
| NEB | ENST00000397345.8 | TSL:5 MANE Select | c.21313-738T>A | intron | N/A | ENSP00000380505.3 | |||
| NEB | ENST00000409198.5 | TSL:5 | c.16245T>A | p.Asp5415Glu | missense | Exon 116 of 150 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152172Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000241 AC: 6AN: 248596 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461360Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726998 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000158 AC: 24AN: 152290Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74456 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Nemaline myopathy 2 Uncertain:1Benign:1
Inborn genetic diseases Uncertain:1
The c.16245T>A (p.D5415E) alteration is located in exon 116 (coding exon 114) of the NEB gene. This alteration results from a T to A substitution at nucleotide position 16245, causing the aspartic acid (D) at amino acid position 5415 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at